Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Functional movement disorders in neurogeriatric inpatients : Underdiagnosed, often comorbid to neurodegenerative disorders and treatable.

Mätzold S, Geritz J, Zeuner KE, Berg D, Paschen S, Hieke J, Sablowsky S, Ortlieb C, Bergmann P, Hofmann W, Espay AJ, Maetzler W.

Z Gerontol Geriatr. 2019 May 28. doi: 10.1007/s00391-019-01562-y. [Epub ahead of print] Review.

PMID:
31139963
2.

Do Adaptors Shorten the Battery Life of Nonrechargeable Generators for Deep Brain Stimulation?

Helmers AK, Birkenfeld F, Deuschl G, Paschen S, Cohrs G, Mehdorn HM, Falk D.

World Neurosurg. 2019 Apr 8. pii: S1878-8750(19)30475-9. doi: 10.1016/j.wneu.2019.02.064. [Epub ahead of print]

PMID:
30974267
3.

Comparing two randomized deep brain stimulation trials for Parkinson's disease.

Deuschl G, Follett KA, Luo P, Rau J, Weaver FM, Paschen S, Steigerwald F, Tonder L, Stoker V, Reda DJ.

J Neurosurg. 2019 Apr 5:1-9. doi: 10.3171/2018.12.JNS182042. [Epub ahead of print]

PMID:
30952118
4.

Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study.

Reich MM, Horn A, Lange F, Roothans J, Paschen S, Runge J, Wodarg F, Pozzi NG, Witt K, Nickl RC, Soussand L, Ewert S, Maltese V, Wittstock M, Schneider GH, Coenen V, Mahlknecht P, Poewe W, Eisner W, Helmers AK, Matthies C, Sturm V, Isaias IU, Krauss JK, Kühn AA, Deuschl G, Volkmann J.

Brain. 2019 May 1;142(5):1386-1398. doi: 10.1093/brain/awz046.

PMID:
30851091
5.

Long-term efficacy of deep brain stimulation for essential tremor: An observer-blinded study.

Paschen S, Forstenpointner J, Becktepe J, Heinzel S, Hellriegel H, Witt K, Helmers AK, Deuschl G.

Neurology. 2019 Mar 19;92(12):e1378-e1386. doi: 10.1212/WNL.0000000000007134. Epub 2019 Feb 20.

PMID:
30787161
6.

Moderate Frequency Resistance and Balance Training Do Not Improve Freezing of Gait in Parkinson's Disease: A Pilot Study.

Schlenstedt C, Paschen S, Seuthe J, Raethjen J, Berg D, Maetzler W, Deuschl G.

Front Neurol. 2018 Dec 10;9:1084. doi: 10.3389/fneur.2018.01084. eCollection 2018.

7.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
8.

Patient Evaluation and Selection for Movement Disorders Surgery: The Changing Spectrum of Indications.

Paschen S, Deuschl G.

Prog Neurol Surg. 2018;33:80-93. doi: 10.1159/000480910. Epub 2018 Jan 12. Review.

PMID:
29332075
9.

Orthostatic myoclonus associated with Caspr2 antibodies.

Gövert F, Witt K, Erro R, Hellriegel H, Paschen S, Martinez-Hernandez E, Wandinger KP, Deuschl G, Dalmau J, Leypoldt F.

Neurology. 2016 Apr 5;86(14):1353-1355. doi: 10.1212/WNL.0000000000002547. Epub 2016 Mar 4. No abstract available.

10.

Resistance versus Balance Training to Improve Postural Control in Parkinson's Disease: A Randomized Rater Blinded Controlled Study.

Schlenstedt C, Paschen S, Kruse A, Raethjen J, Weisser B, Deuschl G.

PLoS One. 2015 Oct 26;10(10):e0140584. doi: 10.1371/journal.pone.0140584. eCollection 2015.

11.

Clinical outcome of deep brain stimulation for Parkinson's disease.

Deuschl G, Paschen S, Witt K.

Handb Clin Neurol. 2013;116:107-28. doi: 10.1016/B978-0-444-53497-2.00010-3. Review.

PMID:
24112889
12.

The central oscillatory network of orthostatic tremor.

Muthuraman M, Hellriegel H, Paschen S, Hofschulte F, Reese R, Volkmann J, Witt K, Deuschl G, Raethjen J.

Mov Disord. 2013 Sep;28(10):1424-30. doi: 10.1002/mds.25616. Epub 2013 Aug 7.

PMID:
23926026
13.

Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor.

Thier S, Lorenz D, Nothnagel M, Poremba C, Papengut F, Appenzeller S, Paschen S, Hofschulte F, Hussl AC, Hering S, Poewe W, Asmus F, Gasser T, Schöls L, Christensen K, Nebel A, Schreiber S, Klebe S, Deuschl G, Kuhlenbäumer G.

Neurology. 2012 Jul 17;79(3):243-8. doi: 10.1212/WNL.0b013e31825fdeed. Epub 2012 Jul 3.

14.

No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients.

Richter J, Appenzeller S, Ammerpohl O, Deuschl G, Paschen S, Brüggemann N, Klein C, Kuhlenbäumer G.

Mov Disord. 2012 Apr;27(4):590-1. doi: 10.1002/mds.24907. Epub 2012 Jan 19. No abstract available.

PMID:
22262231
15.

Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.

Grgic I, Kaistha BP, Paschen S, Kaistha A, Busch C, Si H, Köhler K, Elsässer HP, Hoyer J, Köhler R.

Pflugers Arch. 2009 Jun;458(2):291-302. doi: 10.1007/s00424-008-0619-x. Epub 2008 Nov 27.

PMID:
19037656

Supplemental Content

Loading ...
Support Center